Literature DB >> 27334207

Rheumatoid arthritis: Adalimumab drives Treg cell expansion via membrane TNF.

Sarah Onuora.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27334207     DOI： 10.1038/nrrheum.2016.109

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Anti-TNF drives regulatory T cell expansion by paradoxically promoting membrane TNF-TNF-RII binding in rheumatoid arthritis.

Authors:  Dao Xuan Nguyen; Michael R Ehrenstein
Journal:  J Exp Med       Date:  2016-06-06       Impact factor: 14.307
  1 in total
  2 in total

1.  Massive splenomegaly due to concurrent primary Epstein-Barr virus and cytomegalovirus infection in a patient on adalimumab.

Authors:  Barathy Rani Ramasamy; Patrick Charles; Douglas Johnson; Albert Frauman
Journal:  BMJ Case Rep       Date:  2017-09-01

Review 2.  The role of CD4+FoxP3+ regulatory T cells in the immunopathogenesis of COVID-19: implications for treatment.

Authors:  Yifei Wang; Jingbin Zheng; Md Sahidul Islam; Yang Yang; Yuanjia Hu; Xin Chen
Journal:  Int J Biol Sci       Date:  2021-04-10       Impact factor: 6.580
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.